Phase 3 PET Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
TreatmentSurvivalClassical Hodgkin Lymphoma+6 more
Children's Cancer Group, China96 enrolled1 locationNCT06563245
Not Yet Recruiting
Phase 2Phase 3
A Phase IIb/III Clinical Study to Evaluate the Efficacy and Safety of APC101 in Patients with Postherpetic Neuralgia.
Postherpetic Neuralgia
Andros Pharmaceuticals Pty Ltd333 enrolled1 locationACTRN12625001044415
Recruiting
Phase 3
PSMA PET Combined With MRI for the Detection of PCa
Prostate CancerProstatic NeoplasmPCA+6 more
Telix Pharmaceuticals (Innovations) Pty Limited204 enrolled1 locationNCT07052214
Completed
Phase 2Phase 3
21 day trial into the weight reduction effects of supplementation with 1g and 500mg SolaThin.
weight and appetite in overweight and obese individuals
CYVEX NUTRITION, INC60 enrolled1 locationACTRN12612000198820
Completed
Phase 3
Looking for better treatments for impetigo in Aboriginal children
Impetigo in Aboriginal children
Menzies School of Health Research660 enrolled1 locationACTRN12609000858291